Puma Biotechnology, Inc. (PBYI)

10.29 +0.32 (+3.21%) USD  |  NASDAQ  |  Oct 09, 16:00
10.29 0.00 (0.00%) After-Hours: 16:50
More

Puma Biotechnology Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for PBYI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 06, 2026 --
May 08, 2026 --
February 27, 2026 --
February 20, 2026 --
November 07, 2025 --
August 08, 2025 --
May 16, 2025 --
May 09, 2025 --
February 28, 2025 --
December 23, 2024 --
November 08, 2024 --
August 02, 2024 --
July 26, 2024 --
June 04, 2024 --
June 03, 2024 --
Date Value
May 20, 2024 --
May 03, 2024 --
March 01, 2024 --
February 23, 2024 --
February 13, 2024 --
November 03, 2023 --
September 29, 2023 --
September 22, 2023 --
August 04, 2023 --
May 06, 2023 --
May 05, 2023 --
March 06, 2023 --
March 03, 2023 --
February 25, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Arcutis Biotherapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
Vericel Corp. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade